AAAAAA

   
Results: 1-12 |
Results: 12
CORTICAL MYOCLONUS IN LEVODOPA-RESPONSIVE PARKINSONISM
Authors: CAVINESS JN ADLER CH NEWMAN S CASELLI RJ MUENTER MD
Citation: Jn. Caviness et al., CORTICAL MYOCLONUS IN LEVODOPA-RESPONSIVE PARKINSONISM, Movement disorders, 13(3), 1998, pp. 540-544
HEREDITARY FORM OF PARKINSONISM-DEMENTIA
Authors: MUENTER MD FORNO LS HORNYKIEWICZ O KISH SJ MARAGANORE DM CASELLI RJ OKAZAKI H HOWARD FM SNOW BJ CALNE DB
Citation: Md. Muenter et al., HEREDITARY FORM OF PARKINSONISM-DEMENTIA, Annals of neurology, 43(6), 1998, pp. 768-781
LONG-TERM FOLLOW-UP OF LEVODOPA RESPONSIVENESS IN GENERALIZED DYSTONIA
Authors: DEWEY RB MUENTER MD KISHORE A SNOW BJ
Citation: Rb. Dewey et al., LONG-TERM FOLLOW-UP OF LEVODOPA RESPONSIVENESS IN GENERALIZED DYSTONIA, Archives of neurology, 55(10), 1998, pp. 1320-1323
EXCLUSION OF LINKAGE TO CHROMOSOME-17 IN AN IOWAN FAMILY WITH COMBINED PARKINSONISM AND DEMENTIA
Authors: MARAGANORE DM HUTTON M BAKER M HARDY J ROCCA WA MUENTER MD
Citation: Dm. Maraganore et al., EXCLUSION OF LINKAGE TO CHROMOSOME-17 IN AN IOWAN FAMILY WITH COMBINED PARKINSONISM AND DEMENTIA, Neurology, 48(3), 1997, pp. 3094-3094
LONG-TERM FOLLOW-UP OF LEVODOPA RESPONSIVENESS IN GENERALIZED DYSTONIA
Authors: DEWEY RB MUENTER MD KISHORE A SNOW BJ
Citation: Rb. Dewey et al., LONG-TERM FOLLOW-UP OF LEVODOPA RESPONSIVENESS IN GENERALIZED DYSTONIA, Annals of neurology, 40(3), 1996, pp. 183-183
ADJUNCTIVE CABERGOLINE THERAPY OF PARKINSONS-DISEASE - COMPARISON WITH PLACEBO AND ASSESSMENT OF DOSE RESPONSES AND DURATION OF EFFECT
Authors: AHLSKOG JE WRIGHT KF MUENTER MD ADLER CH
Citation: Je. Ahlskog et al., ADJUNCTIVE CABERGOLINE THERAPY OF PARKINSONS-DISEASE - COMPARISON WITH PLACEBO AND ASSESSMENT OF DOSE RESPONSES AND DURATION OF EFFECT, Clinical neuropharmacology, 19(3), 1996, pp. 202-212
MULTICENTER, PLACEBO-CONTROLLED TRIAL OF CABERGOLINE TAKEN ONCE-DAILYIN THE TREATMENT OF PARKINSONS-DISEASE
Authors: HUTTON JT KOLLER WC AHLSKOG JE PAHWA R HURTIG HI STERN MB HINER BC LIEBERMAN A PFEIFFER RF RODNITZKY RL WATERS CH MUENTER MD ADLER CH MORRIS JL
Citation: Jt. Hutton et al., MULTICENTER, PLACEBO-CONTROLLED TRIAL OF CABERGOLINE TAKEN ONCE-DAILYIN THE TREATMENT OF PARKINSONS-DISEASE, Neurology, 46(4), 1996, pp. 1062-1065
POSTZOSTER ERUPTIONS - GRANULOMA-ANNULARE, GRANULOMATOUS VASCULITIS AND PSEUDOLYMPHOMA
Authors: WINKLEMANN RK CONNOLLY SM YIANNIAS JA MUENTER MD HARMON CB
Citation: Rk. Winklemann et al., POSTZOSTER ERUPTIONS - GRANULOMA-ANNULARE, GRANULOMATOUS VASCULITIS AND PSEUDOLYMPHOMA, EJD. European journal of dermatology, 5(6), 1995, pp. 470-476
TEMPORARY WORSENING OF PARKINSONISM IN A PATIENT WITH PARKINSONS-DISEASE AFTER TREATMENT WITH PACLITAXEL FOR A METASTATIC GRADE-IV ADENOCARCINOMA
Authors: BOWER JH MUENTER MD
Citation: Jh. Bower et Md. Muenter, TEMPORARY WORSENING OF PARKINSONISM IN A PATIENT WITH PARKINSONS-DISEASE AFTER TREATMENT WITH PACLITAXEL FOR A METASTATIC GRADE-IV ADENOCARCINOMA, Movement disorders, 10(5), 1995, pp. 681-682
APHYSIOLOGIC PERFORMANCE ON DYNAMIC POSTUROGRAPHY
Authors: CEVETTE MJ PUETZ B MARION MS WERTZ ML MUENTER MD
Citation: Mj. Cevette et al., APHYSIOLOGIC PERFORMANCE ON DYNAMIC POSTUROGRAPHY, Otolaryngology and head and neck surgery, 112(6), 1995, pp. 676-688
FLUCTUATING PARKINSONS-DISEASE - TREATMENT WITH THE LONG-ACTING DOPAMINE AGONIST CABERGOLINE
Authors: AHLSKOG JE MUENTER MD MARAGANORE DM MATSUMOTO JY LIEBERMAN A WRIGHT KF WHEELER K
Citation: Je. Ahlskog et al., FLUCTUATING PARKINSONS-DISEASE - TREATMENT WITH THE LONG-ACTING DOPAMINE AGONIST CABERGOLINE, Archives of neurology, 51(12), 1994, pp. 1236-1241
LEVODOPA THERAPY AND SURVIVAL IN IDIOPATHIC PARKINSONS-DISEASE - OLMSTED COUNTY PROJECT
Authors: UITTI RJ AHLSKOG JE MARAGANORE DM MUENTER MD ATKINSON EJ CHA RH OBRIEN PC
Citation: Rj. Uitti et al., LEVODOPA THERAPY AND SURVIVAL IN IDIOPATHIC PARKINSONS-DISEASE - OLMSTED COUNTY PROJECT, Neurology, 43(10), 1993, pp. 1918-1926
Risultati: 1-12 |